Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy

The retraction notice states that 'ORI determined that Dr. Gelband is solely responsible for the falsification.'; There is a Findings of scientific misconduct for this article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259650/;